Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06369740 · ClinicalTrials.gov registry record
Case and Use Scenario Study to Gain Knowledge on the User Needs for a Medical Device for Hemophilia a Monitoring
A clinical trial of Hemophilia A, sponsored by Enzyre B.V..
- Completed
- Registry status
- 74
- Enrollment target
- 1
- Study location
NCT06369740 is a study of Hemophilia A that has completed, run by Enzyre B.V.. The registered enrollment target is 74 participants, below the 90-participant average among 42 other Hemophilia A trials with a reported enrollment target (18% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06369740, a study of Hemophilia A, has completed, sponsored by Enzyre B.V..
- COMPLETED
- Registry status
- 74 participants
- Enrollment target
- 1
- Study location
Study Summary
This observational study consists of two parts. In part one, case scenario focus groups with hemophilia A patients and healthcare providers (HCPs) will be held. This parts aims to identify potential use scenarios of a point of care (POC) in vitro medical for patients with hemophilia A. The main questions it aims to answer are: * How is coagulation lab testing for patients with hemophilia A currently organized? * What is the interest and what are desired alternatives of a POC in-vitro diagnostic medical device for patients with hemophilia A? Part two of the study consists of a use scenario study in which patients with hemophilia A and HCPs will evaluate two types of non-functional mock-ups of a POC in vitro medical device. The main goal of this part is to evaluate the usability of the current prototypes of the POC device.
Conditions Studied
Interventions
- OTHER Case scenarios - questionnaire
- OTHER Case scenarios - Focus groups
- OTHER Use scenarios - Usability test
- OTHER Use scenarios - interview
Study Locations (1)
Indiana
- Indiana Hemophilia & Thrombosis Center - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2024-08-22 |
| Est. Completion | 2024-08-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06369740
The ClinicalTrials.gov registry entry for NCT06369740 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 90-participant average among 42 other Hemophilia A trials with a reported enrollment target (18% lower). The listed sponsor is Enzyre B.V., which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hemophilia A appearing as the primary indexed condition, and to 4 interventions - of which Case scenarios - questionnaire is the first listed.
NCT06369740 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT06369740 about?
NCT06369740 is a clinical study titled "Case and Use Scenario Study to Gain Knowledge on the User Needs for a Medical Device for Hemophilia a Monitoring". This observational study consists of two parts. In part one, case scenario focus groups with hemophilia A patients and healthcare providers (HCPs) will be held. This parts aims to identify potential use scenarios of a point of care (POC) in vitro medical for patients with hemophilia A. The main que...
What is the current status of trial NCT06369740?
This trial is currently completed. The enrollment target is 74 participants. The study started on 2024-08-22. Estimated completion is 2024-08-25.
What conditions does trial NCT06369740 study?
This clinical trial studies the following conditions: Hemophilia A.
What interventions are being tested in trial NCT06369740?
The interventions under investigation include: Case scenarios - questionnaire (OTHER), Case scenarios - Focus groups (OTHER), Use scenarios - Usability test (OTHER), Use scenarios - interview (OTHER).
Who is sponsoring clinical trial NCT06369740?
This trial is sponsored by Enzyre B.V., which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06369740 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hemophilia A
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
RECRUITING · Phase 3
-
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
RECRUITING · Phase 3
-
A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
RECRUITING · Phase 1
-
Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery
RECRUITING · Phase 4
-
Hemophilia A Research Program
RECRUITING
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.